9-Months and 12-Months Safety and Exploratory Efficacy Data of ANAVEX 2-73 in a Phase 2a Study
- ANAVEX® Life Sciences Corp.
- Dec 10, 2016
- 1 min read
9th Clinical Trials on Alzheimer’s Disease (CTAD) 2016, San Diego, CA
Associate Professor Stephen Macfarlane, FRANZCP